{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:58:11Z","timestamp":1790225891116,"version":"4.1.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6,15]]},"DOI":"10.1093\/cid\/cit145","type":"journal-article","created":{"date-parts":[[2013,3,14]],"date-time":"2013-03-14T04:27:49Z","timestamp":1363235269000},"page":"1812-1819","source":"Crossref","is-referenced-by-count":75,"title":["Prophylactic Effect of Antiretroviral Therapy on Hepatitis B Virus Infection"],"prefix":"10.1093","volume":"56","author":[{"given":"Hiroyuki","family":"Gatanaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsunefusa","family":"Hayashida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Tanuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,3,13]]},"reference":[{"key":"key\n\t\t\t\t20170623052513_CIT145C1","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/hep.510290447","article-title":"Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men","volume":"29","author":"Colin","year":"1999","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20170623052513_CIT145C2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/jac\/dkp414","article-title":"HIV\/hepatitis B virus co-infection: current challenges and new strategies","volume":"65","author":"Lacombe","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170623052513_CIT145C3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.antiviral.2009.10.021","article-title":"Viral hepatitis and HIV co-infection","volume":"85","author":"Soriano","year":"2010","journal-title":"Antiviral Res"},{"key":"key\n\t\t\t\t20170623052513_CIT145C4","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMp1201796","article-title":"HIB-HBV coinfection\u2014a global challenge","volume":"366","author":"Kourtis","year":"2012","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170623052513_CIT145C5","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1086\/377135","article-title":"Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects","volume":"188","author":"Kellerman","year":"2003","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170623052513_CIT145C6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1468-1293.2003.00152.x","article-title":"HIV\/HBV and HIV\/HCV coinfection, and outcomes following highly active antiretroviral therapy","volume":"4","author":"Lincoln","year":"2003","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t20170623052513_CIT145C7","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S1473-3099(05)70141-9","article-title":"Management of hepatitis co-infected with hepatitis B virus and HIV","volume":"6","author":"Nunez","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20170623052513_CIT145C8","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMra065142","article-title":"Viral hepatitis in HIV infection","volume":"356","author":"Koziel","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170623052513_CIT145C9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.antiviral.2010.07.008","article-title":"Trends in transmitted drug-resistant HIV-1 and demographic characteristics of newly diagnosed patients: nationwide surveillance from 2003 to 2008 in Japan","volume":"88","author":"Hattori","year":"2010","journal-title":"Antivir Res"},{"key":"key\n\t\t\t\t20170623052513_CIT145C10","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1128\/JCM.02149-10","article-title":"Outbreak of infections by hepatitis B virus genotype A and transmission of genetic drug resistance in patients coinfected with HIV-1 in Japan","volume":"49","author":"Fujisaki","year":"2011","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170623052513_CIT145C11","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(02)11913-1","article-title":"HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter AIDS Cohort Study (MACS)","volume":"360","author":"Thio","year":"2002","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170623052513_CIT145C12","doi-asserted-by":"crossref","first-page":"S138","DOI":"10.1002\/hep.22883","article-title":"Hepatitis B and human immunodeficiency virus coinfection","volume":"49","author":"Thio","year":"2009","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20170623052513_CIT145C13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-1293.2009.00781.x","article-title":"British HIV association guidelines for the management of coinfection with HIV-1 and hepatitis B or C virus 2010","volume":"11","author":"Brook","year":"2010","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t20170623052513_CIT145C14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/jama.2012.7961","article-title":"Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International AIDS Society\u2013USA panel","volume":"308","author":"Thompson","year":"2012","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170623052513_CIT145C15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jcv.2011.01.009","article-title":"Performance of the DiaSorin LIAISON anti-HBs II for the detection of hepatitis B surface antibodies: comparison with the Abbott ARCHITECT anti-HBs assay","volume":"50","author":"Kinn","year":"2011","journal-title":"J Clin Virol"},{"key":"key\n\t\t\t\t20170623052513_CIT145C16","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jviromet.2008.09.006","article-title":"Detection of antibodies to hepatitis B core antigen using the Abbott ARCHITECT anti-HBc assay: analysis of borderline reactive sera","volume":"154","author":"Ollier","year":"2008","journal-title":"J Virol Methods"},{"key":"key\n\t\t\t\t20170623052513_CIT145C17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jviromet.2006.07.014","article-title":"Classification of hepatitis B virus genotypes by the PCR-invader method with genotype-specific probes","volume":"138","author":"Tadokoro","year":"2006","journal-title":"J Virol Methods"},{"key":"key\n\t\t\t\t20170623052513_CIT145C18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jviromet.2010.10.001","article-title":"Rapid detection of drug-resistant mutations in hepatitis B virus by the PCR-Invader assay","volume":"171","author":"Tadokoro","year":"2011","journal-title":"J Virol Methods"},{"key":"key\n\t\t\t\t20170623052513_CIT145C19","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2009.08.063","article-title":"Hepatitis B virus resistance to nucleos(t)ide analogues","volume":"137","author":"Zoulim","year":"2009","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20170623052513_CIT145C20","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/jmv.1069","article-title":"Predominance of genotype A HBV in an HBV-HIV-1 dually positive population compared with an HIV-1-negative counterpart in Japan","volume":"64","author":"Koibuchi","year":"2001","journal-title":"J Med Virol"},{"key":"key\n\t\t\t\t20170623052513_CIT145C21","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1128\/JCM.02081-08","article-title":"Distribution of hepatitis B virus genotypes with chronic infection in Japan shifting toward an increase of genotype A","volume":"47","author":"Matsuura","year":"2009","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170623052513_CIT145C22","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1002\/jmv.21309","article-title":"Change of hepatitis B virus genotypes in acute and chronic infections in Japan","volume":"80","author":"Kobayashi","year":"2008","journal-title":"J Med Virol"},{"key":"key\n\t\t\t\t20170623052513_CIT145C23","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1111\/j.1440-1746.2010.06541.x","article-title":"The clinical implications of hepatitis B virus genotype: recent advances","volume":"26","author":"Lin","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t20170623052513_CIT145C24","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1086\/375084","article-title":"Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individuals","volume":"36","author":"Gandhi","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170623052513_CIT145C25","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1086\/515578","article-title":"Isolated hepatitis B core antibody is associated with HIV and ongoing but not resolve hepatitis C virus infection in a cohort of US women","volume":"195","author":"French","year":"2007","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170623052513_CIT145C26","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3748\/wjg.15.1237","article-title":"Clinical significance of \u201canti-HBc alone\u201d in human immunodeficiency virus-positive patients","volume":"15","author":"Perez-Rodriguez","year":"2009","journal-title":"World J Gastroenterol"},{"key":"key\n\t\t\t\t20170623052513_CIT145C27","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.3748\/wjg.15.3834","article-title":"\u201cAnti-HBc alone\u201d in human immunodeficiency virus-positive and immune-suppressed lymphoma patients","volume":"15","author":"Koo","year":"2009","journal-title":"World J Gastroenterol"},{"key":"key\n\t\t\t\t20170623052513_CIT145C28","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1086\/429302","article-title":"Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies","volume":"191","author":"Gandhi","year":"2005","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170623052513_CIT145C29","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1086\/599610","article-title":"Long-term serologic follow-up of isolated hepatitis B core antibody in HIV-infected and HIV-uninfected women","volume":"49","author":"French","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170623052513_CIT145C30","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1056\/NEJM198703053161015","article-title":"Accelerated loss of antibody to hepatitis B surface antigen among immunodeficient homosexual men infected with HIV","volume":"316","author":"Biggar","year":"1987","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170623052513_CIT145C31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7326\/0003-4819-109-2-101","article-title":"Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination","volume":"109","author":"Collier","year":"1988","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20170623052513_CIT145C32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/jmv.1890310207","article-title":"Diminished response to recombinant hepatitis B vaccine in homosexual men with HIV antibody: an indicator of poor prognosis","volume":"31","author":"Loke","year":"1990","journal-title":"J Med Virol"},{"key":"key\n\t\t\t\t20170623052513_CIT145C33","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/00002030-199404000-00024","article-title":"Impaired response to recombinant hepatitis B vaccine in asymptomatic HIV-infected individuals","volume":"8","author":"Tayal","year":"1994","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170623052513_CIT145C34","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1086\/653707","article-title":"Increased regulatory T cell counts in HIV-infected nonresponders to hepatitis B virus vaccine","volume":"202","author":"del Pozo Balado Mdel","year":"2010","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170623052513_CIT145C35","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1016\/j.vaccine.2004.11.057","article-title":"Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose","volume":"23","author":"Fonseca","year":"2005","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170623052513_CIT145C36","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1001\/jama.2011.351","article-title":"Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis vaccine regimen in adults with HIV-1: a randomized controlled trial","volume":"305","author":"Launay","year":"2011","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170623052513_CIT145C37","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/QAI.0b013e318203e9f2","article-title":"Hepatitis B vaccination in HIV-infected youth: a randomized trial of three regimens","volume":"56","author":"Flynn","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170623052513_CIT145C38","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0140-6736(08)61115-0","article-title":"Relation between HIV viral load and infectiousness: a model-based analysis","volume":"372","author":"Wilson","year":"2008","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170623052513_CIT145C39","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":"Prevention of HIV-1 infection with early antiretroviral therapy","volume":"365","author":"Cohen","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170623052513_CIT145C40","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"Grant","year":"2010","journal-title":"N Engl J Med"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/56\/12\/1812\/17850849\/cit145.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T01:02:35Z","timestamp":1503450155000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1093\/cid\/cit145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,13]]},"references-count":40,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,3,13]]},"published-print":{"date-parts":[[2013,6,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cit145","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3,13]]}}}